Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
Wendt, Edgar Heinz Uwe
Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. [electronic resource] - Anticancer research Jan 2020 - 153-160 p. digital
Publication Type: Journal Article
1791-7530
10.21873/anticanres.13936 doi
Antineoplastic Agents--pharmacology
Biomarkers
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Humans
Hypoglycemic Agents--pharmacology
Isocoumarins--pharmacology
Lactic Acid--metabolism
Metformin--pharmacology
Pancreatic Neoplasms--drug therapy
Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. [electronic resource] - Anticancer research Jan 2020 - 153-160 p. digital
Publication Type: Journal Article
1791-7530
10.21873/anticanres.13936 doi
Antineoplastic Agents--pharmacology
Biomarkers
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Humans
Hypoglycemic Agents--pharmacology
Isocoumarins--pharmacology
Lactic Acid--metabolism
Metformin--pharmacology
Pancreatic Neoplasms--drug therapy